Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001520138-25-000056
Filing Date
2025-02-11
Accepted
2025-02-11 17:00:28
Documents
67
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR PERIOD ENDING DECEMBER 31, 2024 bivi-20241231_10q.htm   iXBRL 10-Q 868462
2 EXHIBIT 31.1 bivi-20241230_10qex31z1.htm EX-31.1 12097
3 EXHIBIT 31.2 bivi-20241230_10qex31z2.htm EX-31.2 12262
4 EXHIBIT 32.1 bivi-20241230_10qex32z1.htm EX-32.1 5288
5 EXHIBIT 32.2 bivi-20241230_10qex32z2.htm EX-32.2 5138
  Complete submission text file 0001520138-25-000056.txt   5012995

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE bivi-20241231.xsd EX-101.SCH 43862
7 XBRL CALCULATION FILE bivi-20241231_cal.xml EX-101.CAL 48177
8 XBRL DEFINITION FILE bivi-20241231_def.xml EX-101.DEF 158232
9 XBRL LABEL FILE bivi-20241231_lab.xml EX-101.LAB 366903
10 XBRL PRESENTATION FILE bivi-20241231_pre.xml EX-101.PRE 300829
69 EXTRACTED XBRL INSTANCE DOCUMENT bivi-20241231_10q_htm.xml XML 692939
Mailing Address 680 W NYE LANE SUITE 201 CARSON CITY NV 89703
Business Address 680 W NYE LANE SUITE 201 CARSON CITY NV 89703 775-888-3162
BIOVIE INC. (Filer) CIK: 0001580149 (see all company filings)

EIN.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-39015 | Film No.: 25610689
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)